Eating nuts slashes prostate cancer death risk by a third

Men with prostate cancer could slash their risk of death by more than a third by eating nuts regularly, a major study shows.

Five 1oz servings a week of any type of nut cut mortality rates by 34 per cent, researchers found.

But there was no evidence that eating nuts reduces the risk of developing the disease in the first place.

The results come from the largest ever study into the effects of a nut-rich diet on prostate cancer.

Previous studies have hinted a healthy diet and lifestyle, including frequent snacking on nuts, can have a protective effect. In 2014, scientists found walnuts in particular seemed to significantly lower the risk of a tumour.

In the latest study, tracked 47,000 men over 26 years. They identified 6,800 who developed prostate cancer.

Eating nuts regularly seemed to have little or no benefit in terms of preventing malignant growths.

But when scientists looked at death rates, they found sufferers who ate nuts at least five times a week were 34 per cent less likely to die from their illness than those who ate nuts less than once a month.

Most of the nut-eaters study ate peanuts but the health benefits seem to apply whatever the type of nut. Nuts are rich in tocopherols, a type of vitamin E which some research suggests can combat cancer.

They also contain phyto chemicals, naturally occurring plant chemicals thought to have potent anti-cancer properties. Other studies have found they protect against heart disease and type 2 diabetes.

Reporting their findings, the researchers said: ‘No significant associations were observed between peanut or other nut consumption and prostate cancer incidence. But frequent nut consumption after diagnosis was associated with significantly reduced overall mortality.

‘Patients who consumed nuts five or more times per week had a 34 per cent lower rate of overall mortality compared with those who consumed less than once per month.

‘This suggests nuts, although not associated with being diagnosed with cancer, may still improve the overall survival of patients.’

 

Source :Daily mail

N.H.Kh

 

You might also like
.. _copyright: Copyright ========= .. code-block:: none Copyright (C) 1998-2000 Tobias Ratschiller Copyright (C) 2001-2018 Marc Delisle Olivier Müller Robin Johnson Alexander M. Turek Michal Čihař Garvin Hicking Michael Keck Sebastian Mendel [check credits for more details] This program is free software; you can redistribute it and/or modify it under the terms of the GNU General Public License version 2, as published by the Free Software Foundation. This program is distributed in the hope that it will be useful, but WITHOUT ANY WARRANTY; without even the implied warranty of MERCHANTABILITY or FITNESS FOR A PARTICULAR PURPOSE. See the GNU General Public License for more details. You should have received a copy of the GNU General Public License along with this program. If not, see . Third party licenses ++++++++++++++++++++ phpMyAdmin includes several third-party libraries which come under their respective licenses. jQuery's license, which is where we got the files under js/vendor/jquery/ is (MIT|GPL), a copy of each license is available in this repository (GPL is available as LICENSE, MIT as js/vendor/jquery/MIT-LICENSE.txt). The download kit additionally includes several composer libraries. See their licensing information in the vendor/ directory.